Friday, February 11, 2011
Morristown Regional Cancer Center Welcomes Thompson Oncology Group
On March 7th, The Morristown Regional Cancer Center (MRCC)
at Morristown-Hamblen Healthcare System
will welcome Thompson Oncology Group, a division of Thompson Cancer Survival Center
. The physician group will be seeing medical oncology patients and managing patients receiving Chemotherapy Infusion. Thompson Oncology Group and Thompson Cancer Survival Center are a part of Covenant Health and the most comprehensive cancer program in East Tennessee.
MHHS initiated medical oncology and chemotherapy infusion services in 1995, and opened a dedicated cancer center in 2004. Over the years MHHS has partnered with a number of different physicians and organizations to offer a full compliment of cancer services locally. “As a member of Covenant Health, I am excited about the future contributions The Thompson Oncology Group will provide to our local medical staff and community,” stated Richard Clark, MHHS President and CAO.
“Thompson is excited to be part of the local medical community, and we see this partnership with MHHS as the first step in continued development of Oncology services in Morristown,” said Gordon Lintz, Thompson Cancer Survival Center President and CAO. Future plans include linking into Thompson’s multi-disciplinary breast, thoracic and neuro-oncology conferences as well as bringing clinical research studies to the local community. Opening of the Morristown office will be the tenth location of Thompson Oncology Group, which now serves 16 East Tennessee Counties.
“I am very optimistic about the addition of Thompson Oncology Group and the direction our cancer program is progressing,” added Dr. John Anderson, MRCC Radiation Oncologist / MRCC Medical Director. The Morristown Regional Cancer Center is a growing clinical service line, as is evident by the recent approval by the State of TN to add a fixed site PET/CT Unit. Plans are underway to prepare our MRCC for accreditation by the American College of Surgeons as a Community Cancer Center within the next two years. “Our community has much to look forward to as we continue to grow and develop locally based services to treat and care for cancer patients and their families,” added Clark. In addition, The Morristown-Hamblen Hospital Foundation has initiated a capital campaign to build a dedicated inpatient oncology unit, of which Covenant Health has committed, $2 Million to match the Foundation’s fundraising efforts.
MRCC has grown into a true regional provider of comprehensive oncology prevention, diagnosis and treatment services. Each year MRCC touches countless lives by giving hope to cancer patients through thousands of radiation therapy treatments, and chemotherapy infusion treatments, and surgical / medical interventions. The MRCC uses a multidisciplinary approach to fighting cancer through a weekly Tumor Conference in which Medical Oncologists, Radiation Oncologists, Surgeons, Radiologists, and Pathologists come together as a group to discuss the best plan of care on individual patient cases.
For more information, or to schedule an appointment, contact the Morristown Regional Cancer Center at 423-522-5000.